Royalty Pharma plc (RPRX)
NASDAQ: RPRX · IEX Real-Time Price · USD
30.37
-0.08 (-0.26%)
At close: Mar 28, 2024, 4:00 PM
30.68
+0.31 (1.02%)
After-hours: Mar 28, 2024, 7:32 PM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $18.19 billion as of March 28, 2024. Its market cap has decreased by -14.86% in one year.
Market Cap
18.19B
Enterprise Value
23.09B
1-Year Change
-14.86%
Ranking
Category
Stock Price
$30.37
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has decreased from $26.49B to $18.19B, a decrease of -31.34%. That is a compound annual growth rate of -9.47%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 18.19B | 0.73% |
Mar 26, 2024 | 18.06B | -0.16% |
Mar 25, 2024 | 18.09B | 0.03% |
Mar 22, 2024 | 18.08B | -0.53% |
Mar 21, 2024 | 18.18B | 0.07% |
Mar 20, 2024 | 18.17B | 0.76% |
Mar 19, 2024 | 18.03B | 0.43% |
Mar 18, 2024 | 17.95B | -0.13% |
Mar 15, 2024 | 17.98B | 0.80% |
Mar 14, 2024 | 17.83B | -0.10% |
Mar 13, 2024 | 17.85B | -1.55% |
Mar 12, 2024 | 18.13B | 0.90% |
Mar 11, 2024 | 17.97B | -0.96% |
Mar 8, 2024 | 18.14B | 1.10% |
Mar 7, 2024 | 17.95B | 1.01% |
Mar 6, 2024 | 17.77B | 1.05% |
Mar 5, 2024 | 17.58B | -1.54% |
Mar 4, 2024 | 17.86B | -0.13% |
Mar 1, 2024 | 17.88B | -1.35% |
Feb 29, 2024 | 18.13B | -0.88% |
Feb 28, 2024 | 18.29B | -2.20% |
Feb 27, 2024 | 18.70B | -0.10% |
Feb 26, 2024 | 18.72B | 0.97% |
Feb 23, 2024 | 18.54B | 0.03% |
Feb 22, 2024 | 18.53B | -0.67% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
The Cooper Companies | 20.02B |
Alnylam Pharmaceuticals | 19.08B |
Koninklijke Philips | 18.40B |
Laboratory Corporation of America Holdings | 18.21B |
Walgreens Boots Alliance | 18.15B |
Hologic | 17.88B |
BeiGene | 17.01B |
BioMarin Pharmaceutical | 16.55B |